Sun Pharma gains 3% on USFDA approval for psoriasis drug Ilumya

Ilumya is used for the treatment of the most common plaque psoriasis – a chronic immune disease that appears on the skin.

Shares of Sun Pharmaceutical Industries gained 3.4 percent in the early trade on Thursday as it has received USFDA approval for its psoriasis drug Ilumya.

To Get Free Trial
Missed call @ 9582541010 
Call Us @ 8822117117 
Mail Us = starindiamarket@gmail.com 
Visit = http://www.starindiaresearch.com/freetrail.php